U.S. FDA Approves Eagle’s Generic Version of Blood Pressure Drug

Eagle Pharmaceuticals Inc said on Wednesday the U.S. Food and Drug Administration approved its generic version of Vasostrict, a blood pressure drug developed by Endo International’s subsidiary Par Pharmaceutical Inc. Read More